Safety and efficacy of atezolizumab in the treatment of cancers: a systematic review and pooled-analysis.

Immune checkpoint inhibitors have developed rapidly and have demonstrated antitumor activity in various cancers. To evaluate the safety and efficacy of atezolizumab in treating cancers, we conducted this meta-analysis.